N‐substituted hydroxynaphthalene imino‐oxindole derivatives as new class of PI3‐kinase inhibitor and breast cancer drug: Molecular validation and structure–activity relationship studies

Publisher: John Wiley & Sons Inc

E-ISSN: 1747-0285|91|1|277-284

ISSN: 1747-0277

Source: CHEMICAL BIOLOGY & DRUG DESIGN (ELECTRONIC), Vol.91, Iss.1, 2018-01, pp. : 277-284

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content